Link to article on Factset Insight: https://insight.factset.com/investors-and-traders-need-to-track-prescription-drug-user-fee-act-pdufa-content
Summary:
PDUFA dates and content are essential for portfolio managers of healthcare stocks. A single positive or negative announcement from the U.S. Food and Drug Administration (FDA) can send shares of a biotech firm soaring or turn a hot name quickly into a bear market.
Related Content
-
Earnings Hold the Line as Retailers get Ready to Report Amid Major Sector Rotation and Tech Fallout
-
2026 Themes Emerge Leading Into a Busy Q1 Second Half Investor Conference Season
-
The Great AI Squeeze: High Costs Take Center Stage in Hyperscalers’ Earnings Reports
-
Investor Days to Watch: What Utilities, Energy, Industrials, and Banks Could Tell Markets
-
Interim Data Spotlight: TSM, TSLA and COST
-
Tech Rebound Soothes Greenland-Induced Shivers, Just as Earnings Season Hits Its Stride
-
Energy Stocks Steady Amid Macro Chaos, with a Sunday Night Earnings Surprise Ahead
-
Did the Banks Just Set the Stage for Another Quarter of Double-Digit S&P 500 EPS Growth?
-
A Quiet Start to 2026 Macro—If You Ignore Everything That’s Happening
-
Q4 2025 Earnings Preview: Can Corporate Profits Sustain S&P 500 Record Highs?
